PFIZER INC
Pfizer holds briefing to present important researchdevelopment
Pfizer holds briefing to present important research developments against malaria, SARS and smallpox
New York, June 25 /PRNewswire/ --
What: PRESS BRIEFING AND Q&A
When: 2:00 PM ET THURSDAY, JUNE 26, 2003
Where: PFIZER CONFERENCE CENTER, NEW YORK, NY
150 E. 42nd Street (between Lexington & Third Aves.) Lower Level -Cameras welcome
Who:
- Hank McKinnell, Chairman and CEO - Pfizer Inc
- Dr. Peter Corr, Senior Vice President, Science & Technology, Pfizer Inc
- Dr. Solomon Nwaka, Scientific Officer, Head of Drug Discovery, Medicines for Malaria Venture, Geneva, Switzerland
- Dr. Mike Dunne, Vice President, Development Leader, Infectious Diseases, Pfizer Global R&D
- Dr. Dave Matthews, Senior Research Fellow, Head of Crystallography,
La Jolla Laboratories, Pfizer Global R&D
LIVE WEBCAST: http://webevents.broadcast.com/pfizer/webcast626 VIDEO HIGHLIGHTS AVAILABLE VIA SATELLITE FOLLOWING THE BRIEFING:
Thurs. June 26, 4:30-4:45PM EDT Fri. June 27, 10:00-10:30AM EDT
Thurs. June 26, 7:00-7:15PM EDT (FED ROTATION) Telstar 4, Transponder 11 C-Band Telstar 6, Transponder 22 C Band
Downlink Frequency 3920 Vertical Downlink Frequency 4140 Horizontal
Contacts:
Andy McCormick Mariann Caprino Pfizer Inc Pfizer Inc
+1 212-573-1226 +1 212-733-4554
Note: Reporters will need to notify Pfizer and be placed on the security
list prior to the event in order to enter the building.
Andy McCormick, Pfizer Inc, +1 212-573-1226, Mariann Caprino, Pfizer Inc,
+1 212-733-4554
26 jun 03 11:57